These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3390864)

  • 21. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.
    Berry M; Metzger D; Chambon P
    EMBO J; 1990 Sep; 9(9):2811-8. PubMed ID: 2118104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain.
    Beekman JM; Allan GF; Tsai SY; Tsai MJ; O'Malley BW
    Mol Endocrinol; 1993 Oct; 7(10):1266-74. PubMed ID: 8264659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of estrogen receptor-alpha by the heavy metal cadmium.
    Stoica A; Katzenellenbogen BS; Martin MB
    Mol Endocrinol; 2000 Apr; 14(4):545-53. PubMed ID: 10770491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140.
    Peters GA; Khan SA
    Mol Endocrinol; 1999 Feb; 13(2):286-96. PubMed ID: 9973258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
    Métivier R; Penot G; Flouriot G; Pakdel F
    Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-steroid action in cultured L-929 mouse fibroblasts.
    Jung-Testas I; Baulieu EE
    J Steroid Biochem; 1984 Jan; 20(1):301-6. PubMed ID: 6708516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms.
    Burnstein KL; Jewell CM; Sar M; Cidlowski JA
    Mol Endocrinol; 1994 Dec; 8(12):1764-73. PubMed ID: 7708063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric receptors used to probe the DNA-binding domain of the estrogen and glucocorticoid receptors.
    Green S; Chambon P
    Cancer Res; 1989 Apr; 49(8 Suppl):2282s-2285s. PubMed ID: 2702667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific.
    Bocquel MT; Kumar V; Stricker C; Chambon P; Gronemeyer H
    Nucleic Acids Res; 1989 Apr; 17(7):2581-95. PubMed ID: 2717402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
    Stoica A; Pentecost E; Martin MB
    Endocrinology; 2000 Oct; 141(10):3595-602. PubMed ID: 11014213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anti-estrogen hydroxytamoxifen is a potent antagonist in a novel yeast system.
    Liu JW; Jeannin E; Picard D
    Biol Chem; 1999 Nov; 380(11):1341-5. PubMed ID: 10614829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
    Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ
    Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region.
    Ali S; Metzger D; Bornert JM; Chambon P
    EMBO J; 1993 Mar; 12(3):1153-60. PubMed ID: 8458328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization.
    Fawell SE; White R; Hoare S; Sydenham M; Page M; Parker MG
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6883-7. PubMed ID: 2395882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An estrogen-responsive element-targeted histone deacetylase enzyme has an antiestrogen activity that differs from that of hydroxytamoxifen.
    Demirpence E; Semlali A; Oliva J; Balaguer P; Badia E; Duchesne MJ; Nicolas JC; Pons M
    Cancer Res; 2002 Nov; 62(22):6519-28. PubMed ID: 12438246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
    Shah YM; Rowan BG
    Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
    Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
    Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.